Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3Phase EARLY_PHASE1 1

Status

Recruiting 2Withdrawn 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 12Recurrence 9Neoplasms 8Colorectal Neoplasms 8Pancreatic Neoplasms 7Leukemia, Myeloid, Acute 7Hematologic Neoplasms 7Carcinoma, Hepatocellular 7Lymphoma, B-Cell 6Sarcoma 5Prostatic Neoplasms 5Breast Neoplasms 5Neoplasms, Plasma Cell 4Myasthenia Gravis 4Lymphoma 4Lung Neoplasms 4Glioblastoma 4Burkitt Lymphoma 4Brain Neoplasms 4Advanced Solid Tumors 4Stomach Neoplasms 3Solid Tumor 3Ovarian Neoplasms 3Melanoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Head and Neck Neoplasms 3Glioma 3Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Not yet recruiting × Immunoglobulin Light-chain Amyloidosis × Clear all
NCT07615270 2026-05-29

A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement

Stanford University

Phase EARLY_PHASE1 Not yet recruiting
5 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡